OTCMKTS:ATBPD

Antibe Therapeutics - ATBPD Stock Forecast, Price & News

$0.44

-0.02 (-4.35%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.44
▼
$0.44
50-Day Range: $0.36
▼
$0.53
52-Week Range: $2.64
▼
$3.50

Volume: 12,000 shs
Average Volume: 29,710 shs
Market Capitalization: $170.05 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Antibe Therapeutics (OTCMKTS:ATBPD) Stock

Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Its drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. The company's lead compound is ATB-346, a hydrogen sulfide-releasing derivative of naproxen for treating rheumatoid arthritis, ankylosing spondylitis, and general pain reduction that has completed Phase 2B gastrointestinal safety study. Its products also comprise ATB-352, which is in preclinical stage for the treatment of gout, dental pain, post-surgical pain, etc.; and ATB-340 that is in preclinical development stage for the treatment of stroke and cancer. In addition, it offers bone graft substitutes, barrier membranes, and other products for the dental and orthopedic markets under the C-Graft Putty, C-Blast Putty, Eclipse, NeoGuarde, Neomem, Neomem FlexPlus, PentOS OI, and Raptos trademarks. The company was incorporated in 2009 and is headquartered in Toronto, Canada.

Receive ATBPD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATBPD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

30 days | 90 days | 365 days | Advanced Chart

Receive ATBPD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:ATBPD
CUSIP: N/A
CIK: N/A
Web: www.antibethera.com
Phone: 416 922 3460
Fax: N/A
Employees: 47
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.60)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-14,540,000.00
Net Margins: -273.96%
Pretax Margin: N/A
Return on Equity: -150.49%
Return on Assets: -98.51%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.97
Quick Ratio: 5.42

Sales & Book Value

Annual Sales: $7.51 million
Price / Sales: 22.64
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.10 per share
Price / Book: 4.39

Miscellaneous

Outstanding Shares: 387,000,000
Free Float: N/A
Market Cap: $170.05 million
Optionable: Not Optionable
Beta: 0.57

Key Executives

Mr. Daniel Marcel Legault (Age 62)
Pres, CEO, Sec. & Director

Dr. John Lawrence Wallace M.B.A. (Age 63)
M.Sc., MSc, Ph.D., MBA, Founder, Chief Scientific Officer & Director

Mr. Alain Wilson M.B.A.
MBA, Chief Financial Officer

Dr. David James Vaughan (Age 70)
Chief Devel. Officer

Mr. Scott Curtis C.F.A.
M.Eng, CFA, Exec. VP

Ms. Christina Cameron B.B.A.
VP of Investor Relations

Mr. Philip Stern
VP of Communications

Dr. Rami Batal M.B.A.
Ph.D., Chief Commercial Officer

Ms. Ella Korets Smith M.B.A.
M.Sc., Head of Regional Bus. Devel.

Dr. Joseph Stauffer (Age 54)
Chief Medical Officer

Key Competitors

View All Competitors

ATBPD Stock - Frequently Asked Questions

How have ATBPD shares performed in 2023?: Antibe Therapeutics' stock was trading at $0.3230 at the beginning of 2023. Since then, ATBPD shares have increased by 36.0% and is now trading at $0.4394.
View the best growth stocks for 2023 here.
What is Antibe Therapeutics' stock symbol?: Antibe Therapeutics trades on the OTCMKTS under the ticker symbol "ATBPD."

How do I buy shares of Antibe Therapeutics?: Shares of ATBPD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Antibe Therapeutics' stock price today?: One share of ATBPD stock can currently be purchased for approximately $0.44.
How much money does Antibe Therapeutics make?: Antibe Therapeutics (OTCMKTS:ATBPD) has a market capitalization of $170.05 million and generates $7.51 million in revenue each year. The company earns $-14,540,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.
How can I contact Antibe Therapeutics?: Antibe Therapeutics' mailing address is 15 PRINCE ARTHUR AVENUE, TORONTO A6, M5R 1B2. The official website for the company is www.antibethera.com. The company can be reached via phone at 416 922 3460 or via email at christina@antibethera.com.

This page (OTCMKTS:ATBPD) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial